Cleveland-Cliffs Inc (NYSE: CLF) Is Rated A Buy By Analysts.
In the last trading session, 31.72 million Cleveland-Cliffs Inc (NYSE:CLF) shares changed hands as the company’s beta touched 1.90. With the company’s per share price
In the last trading session, 31.72 million Cleveland-Cliffs Inc (NYSE:CLF) shares changed hands as the company’s beta touched 1.90. With the company’s per share price
In the last trading session, 10.33 million Microvast Holdings Inc (NASDAQ:MVST) shares changed hands as the company’s beta touched 3.02. With the company’s per share
In the last trading session, 1.23 million Precigen Inc (NASDAQ:PGEN) shares changed hands as the company’s beta touched 1.78. With the company’s per share price
In the last trading session, 2.23 million Sangamo Therapeutics Inc (NASDAQ:SGMO) shares changed hands as the company’s beta touched 1.24. With the company’s per share
In the last trading session, 1.18 million Skyline Builders Group Holding Ltd (NASDAQ:SKBL) shares changed hands as the company’s beta touched 0. With the company’s
In the last trading session, 6.2 million American Battery Technology Company (NASDAQ:ABAT) shares changed hands as the company’s beta touched 1.20. With the company’s per
In the last trading session, 1.2 million ParaZero Technologies Ltd (NASDAQ:PRZO) shares changed hands as the company’s beta touched -0.43. With the company’s per share
In the last trading session, 2.35 million NanoVibronix Inc (NASDAQ:NAOV) shares changed hands as the company’s beta touched 1.78. With the company’s per share price
In the last trading session, 1.5 million Esperion Therapeutics Inc (NASDAQ:ESPR) shares changed hands as the company’s beta touched 0.70. With the company’s per share
In the last trading session, 1.35 million Vera Therapeutics Inc (NASDAQ:VERA) shares changed hands as the company’s beta touched 1.16. With the company’s per share
© 2024, Powered by Smart TechOne